Literature DB >> 16685541

Immunohistochemical evaluation of a novel clone of monoclonal anti-MYCN antibody B8.4B in neuroblastic tumours: a correlation with MYCN gene status.

Rosa Noguera, Marta Piqueras, Manish Subramaniam, Julia Cruz, Adela Cañete, Antonio Llombart Bosch, Samuel Navarro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16685541     DOI： 10.1007/s00428-006-0227-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN： 0945-6317            Impact factor:   4.064


× No keyword cloud information.
  5 in total

1.  Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines.

Authors:  P F Ambros; I M Ambros
Journal:  Med Pediatr Oncol       Date:  2001-12

2.  MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN.

Authors:  S L Cohn; W B London; D Huang; H M Katzenstein; H R Salwen; T Reinhart; J Madafiglio; G M Marshall; M D Norris; M Haber
Journal:  J Clin Oncol       Date:  2000-11-01       Impact factor: 44.544

3.  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.

Authors:  R C Seeger; G M Brodeur; H Sather; A Dalton; S E Siegel; K Y Wong; D Hammond
Journal:  N Engl J Med       Date:  1985-10-31       Impact factor: 91.245

4.  Immunohistochemical analysis of N-myc protein expression in neuroblastoma: correlation with prognosis of patients.

Authors:  E Hiyama; K Hiyama; T Yokoyama; T Ishii
Journal:  J Pediatr Surg       Date:  1991-07       Impact factor: 2.545

5.  MYCN protein expression as a predictor of neuroblastoma prognosis.

Authors:  H S Chan; B L Gallie; G DeBoer; G Haddad; N Ikegaki; J Dimitroulakos; H Yeger; V Ling
Journal:  Clin Cancer Res       Date:  1997-10       Impact factor: 12.531
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.